These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 32926812)

  • 21. Multimodal imaging selection for IV alteplase in unknown time of onset stroke: Are we there yet?
    Urrutia VC
    Neurology; 2020 Dec; 95(22):989-990. PubMed ID: 33097600
    [No Abstract]   [Full Text] [Related]  

  • 22. Thrombectomy within 8 hours after symptom onset in ischemic stroke.
    Jovin TG; Chamorro A; Cobo E; de Miquel MA; Molina CA; Rovira A; San Román L; Serena J; Abilleira S; Ribó M; Millán M; Urra X; Cardona P; López-Cancio E; Tomasello A; Castaño C; Blasco J; Aja L; Dorado L; Quesada H; Rubiera M; Hernandez-Pérez M; Goyal M; Demchuk AM; von Kummer R; Gallofré M; Dávalos A;
    N Engl J Med; 2015 Jun; 372(24):2296-306. PubMed ID: 25882510
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanical thrombectomy after intravenous alteplase versus alteplase alone after stroke (THRACE): a randomised controlled trial.
    Bracard S; Ducrocq X; Mas JL; Soudant M; Oppenheim C; Moulin T; Guillemin F;
    Lancet Neurol; 2016 Oct; 15(11):1138-47. PubMed ID: 27567239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Letter to the Editor Regarding "Intravenous Alteplase in a Patient With Acute Ischemic Stroke Subsequent to Purulent Meningitis".
    Wong ML; Edlow JA
    Ann Emerg Med; 2022 Nov; 80(5):474-475. PubMed ID: 36265925
    [No Abstract]   [Full Text] [Related]  

  • 25. In imaging-selected ischemic stroke with unknown onset, alteplase increases favorable outcomes and death at 90 d.
    Hill MD
    Ann Intern Med; 2021 Apr; 174(4):JC42. PubMed ID: 33819060
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute Treatment of Ischemic Stroke.
    Lyden S; Wold J
    Neurol Clin; 2022 Feb; 40(1):17-32. PubMed ID: 34798968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Recombinant Tissue Plasminogen Activator Does Not Impact Mortality in Acute Ischemic Stroke at Any Time Point up to 6 Months: A Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials.
    Kumar G; Uhrig D; Fowler S; DeLaney MC; Alexandrov AV
    CNS Drugs; 2015 Aug; 29(8):659-67. PubMed ID: 26251162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
    Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
    Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenecteplase versus alteplase for acute ischemic stroke.
    González RG
    N Engl J Med; 2012 Jul; 367(3):275-6; author reply 276. PubMed ID: 22808969
    [No Abstract]   [Full Text] [Related]  

  • 30. Alteplase for ischemic stroke: A giant with feet of clay?
    Brigo F
    Acta Neurol Scand; 2022 Sep; 146(3):318-319. PubMed ID: 35920552
    [No Abstract]   [Full Text] [Related]  

  • 31. Tenecteplase versus alteplase before endovascular thrombectomy (EXTEND-IA TNK): A multicenter, randomized, controlled study.
    Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Dowling RJ; Bush SJ; Dewey HM; Thijs V; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Ang T; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Bailey P; Rice H; de Villiers L; Scroop R; Collecutt W; Wong AA; Coulthard A; Barber PA; McGuinness B; Field D; Ma H; Chong W; Chandra RV; Bladin CF; Brown H; Redmond K; Leggett D; Cloud G; Madan A; Mahant N; O'Brien B; Worthington J; Parker G; Desmond PM; Parsons MW; Donnan GA; Davis SM;
    Int J Stroke; 2018 Apr; 13(3):328-334. PubMed ID: 28952914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endovascular therapy for ischemic stroke with perfusion-imaging selection.
    Campbell BC; Mitchell PJ; Kleinig TJ; Dewey HM; Churilov L; Yassi N; Yan B; Dowling RJ; Parsons MW; Oxley TJ; Wu TY; Brooks M; Simpson MA; Miteff F; Levi CR; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Priglinger M; Ang T; Scroop R; Barber PA; McGuinness B; Wijeratne T; Phan TG; Chong W; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
    N Engl J Med; 2015 Mar; 372(11):1009-18. PubMed ID: 25671797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACP Journal Club. In ischemic stroke, early intraarterial treatment plus alteplase improved reperfusion and functional outcome.
    Jacquin G; Oczkowski W
    Ann Intern Med; 2015 May; 162(10):JC2-4. PubMed ID: 25984877
    [No Abstract]   [Full Text] [Related]  

  • 36. Treatment of acute ischaemic stroke with thrombolysis or thrombectomy in patients receiving anti-thrombotic treatment.
    Diener HC; Foerch C; Riess H; Röther J; Schroth G; Weber R
    Lancet Neurol; 2013 Jul; 12(7):677-88. PubMed ID: 23726849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous tenecteplase compared with alteplase for acute ischemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
    Ferguson E; Yadav K
    CJEM; 2023 Feb; 25(2):121-122. PubMed ID: 36577932
    [No Abstract]   [Full Text] [Related]  

  • 38. Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply.
    Churilov L; Bivard A; Parsons MW
    Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270302
    [No Abstract]   [Full Text] [Related]  

  • 39. CE: Acute Ischemic Stroke.
    Washington HH; Glaser KR; Ifejika NL
    Am J Nurs; 2021 Sep; 121(9):26-33. PubMed ID: 34492666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review.
    Qureshi AI; Malik AA; Freese M; Thompson MJ; Khan AA; Suri MF
    Am J Emerg Med; 2015 Feb; 33(2):307.e1-4. PubMed ID: 25190550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.